Activation of Type I and Type III Interferons in Chronic Hepatitis C. (Q38376179)

PubMed publication ID

2 September 2017

1 reference

title

Activation of Type I and Type III Interferons in Chronic Hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6738759&resulttype=core&format=json

12 May 2020

1 reference

1

Sabine Mihm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6738759&resulttype=core&format=json

12 May 2020

publication date

28 January 2015

1 reference

PubMed publication ID

25766746

Journal of Innate Immunity

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6738759&resulttype=core&format=json

12 May 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6738759&resulttype=core&format=json

12 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6738759&resulttype=core&format=json

12 May 2020

page(s)

251-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6738759&resulttype=core&format=json

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection

12 May 2020

cites work

1 reference

12 December 2020

Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells

1 reference

12 December 2020

Antiviral treatment of hepatitis C.

1 reference

12 December 2020

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

1 reference

12 December 2020

The ins and outs of hepatitis C virus entry and assembly

1 reference

12 December 2020

Loss of function of the new interferon IFN-λ4 may confer protection from hepatitis C

1 reference

12 December 2020

Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.

1 reference

12 December 2020

Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection

1 reference

12 December 2020

Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)

1 reference

12 December 2020

Interferon type I gene expression in chronic hepatitis C.

1 reference

12 December 2020

Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system

1 reference

12 December 2020

Hepatitis: New route of HCV transmission

1 reference

12 December 2020

MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha

1 reference

12 December 2020

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

1 reference

12 December 2020

The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response

1 reference

12 December 2020

Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates

1 reference

12 December 2020

Diverse intracellular pathogens activate type III interferon expression from peroxisomes

1 reference

12 December 2020

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

12 December 2020

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

1 reference

12 December 2020

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

12 December 2020

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

1 reference

12 December 2020

The role of Kupffer cells in hepatitis B and hepatitis C virus infections.

1 reference

12 December 2020

Evolving epidemiology of hepatitis C virus

1 reference

12 December 2020

Activation and evasion of antiviral innate immunity by hepatitis C virus.

1 reference

12 December 2020

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome

1 reference

12 December 2020

In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus

1 reference

12 December 2020

Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization

1 reference

12 December 2020

HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons

1 reference

12 December 2020

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

1 reference

12 December 2020

Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus

1 reference

12 December 2020

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

12 December 2020

The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs

1 reference

12 December 2020

Interferon-λ in the context of viral infections: production, response and therapeutic implications

1 reference

12 December 2020

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

12 December 2020

Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma Cells

1 reference

12 December 2020

Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC.

1 reference

12 December 2020

Regulation of type I interferon responses

1 reference

12 December 2020

Analysis of the transcriptome and immune function of monocytes during IFNα-based therapy in chronic HCV revealed induction of TLR7 responsiveness

1 reference

12 December 2020

Interferon-stimulated genes and their role in controlling hepatitis C virus

1 reference

12 December 2020

Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C.

1 reference

12 December 2020

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

12 December 2020

Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples

1 reference

12 December 2020

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

12 December 2020

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

12 December 2020

Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis C.

1 reference

12 December 2020

Pattern recognition receptors and the innate immune response to viral infection

1 reference

12 December 2020

Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection.

1 reference

12 December 2020

IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection

1 reference

12 December 2020

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

12 December 2020

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies

1 reference

12 December 2020

Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis

1 reference

12 December 2020

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

12 December 2020

Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells.

1 reference

12 December 2020

Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method

1 reference

12 December 2020

Virus interference. I. The interferon

1 reference

12 December 2020

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

1 reference

12 December 2020

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

12 December 2020

Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.

1 reference

12 December 2020

Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus.

1 reference

12 December 2020

Induction of type I interferon by RNA viruses: cellular receptors and their substrates

1 reference

12 December 2020

Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity

1 reference

12 December 2020

1 reference

12 December 2020

Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection

1 reference

12 December 2020

Identifiers

DOI

10.1159/000369973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6738759&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6738759&resulttype=core&format=json

12 May 2020

PubMed publication ID

25766746

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6738759&resulttype=core&format=json